Dr. Piotr Ponikowski and Dr. C. Michael Gibson Discuss: Benefit Of Dapagliflozin On First And Repeat Events In Patients With HFrEF In DAPA-HF April 3, 2020 2020 | ACC | Cardiology Tags: 2020, ACC, Cardiology http://tv.clinicaltrialresults.org/file_repos/56/2484-2456.mp4 Article Navigation Dr. Vincent Nijenhuis and Dr. C. Michael Gibson Discuss: Antithrombotic Therapy After Transcatheter Aortic Valve Implantation In Patients With A Long-term Indication For Oral Anticoagulation (POPular TAVI Trial – Cohort B) Dr. Sripal Bangalore and Dr. C. Michael Gibson Discuss: Clinical And Quality Of Life Outcomes With Invasive Versus Conservative Strategy In Patients With Stable Ischemic Heart Disease Across The Spectrum Of Baseline Kidney Function: Insights From The ISCHEMIA And ISCHEMIA-CKD Trials
